Skip to main content
. 2020 Nov 20;11(11):997. doi: 10.1038/s41419-020-03213-2

Fig. 2. Heatmaps summarizing differentially methylated fragments/genes analyzed by the unit of Mspl fragments, CpG islands, gene body, and promoter.

Fig. 2

MDS pathogenesis indicated the difference compared between MDS and controls. MDS progression indicated the difference compared between sAML and MDS. The fragments/genes that passed statistical significance (paired/independent T test-P < 0.05, and also had >25% mean methylation difference) were considered as differentially methylated fragments/genes.